Tardive dyskinesia: Who is at risk?

Acta Psychiatrica Scandinavica

Volumn 96, Issue 3, 1997, Pages 206-216

  Van Os, J ^a   Fahy, T ^b   Jones, P ^c   Harvey, I ^d   Toone, B ^b   Murray, R ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d Coventry Mental Health Unit ^*  (United Kingdom)

Author keywords

Neuroleptic drugs; Psychosis; Risk factor; Tardive dyskinesia

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LITHIUM; NEUROLEPTIC AGENT;

ARTICLE; DISEASE COURSE; DRUG ALCOHOL INTERACTION; ETHNIC GROUP; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; TARDIVE DYSKINESIA;

EID: 0030843514     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb10153.x     Document Type: Article

References (35)

1. KANE JM, WOERNER M. BORENSTEIN M et al. Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacol Bull 1986: 22: 254-258.
2. YASSA R, JESTE DV. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 1992: 18: 701-715.
3. EDWARDS H. The significance of brain damage in persistent oral dyskinesia. Br J Psychiatry 1970: 116: 271-285.
4. WEGNER JT, KANE JM, WEINHOLD P et al. Cognitive impairment in tardive dyskinesia. Psychiatr Res 1985: 16: 331-337.
5. WADDINGTON JL, YOUSSEF HA, MOLLOY AG et al. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia, clinical and animal studies. J Clin Psychiatry 1985: 46: 29-33.
6. LIDDLE PF, BARNES TRE, SPELLER J, KIBEL D. Negative symptoms as a risk factor for tardive dyskinesia. Br J Psychiatry 1993: 163: 776-780.
7. KANE JM, WOERNER M, WEINHOLD P et al. A prospective study of tardive dyskinesia development, preliminary results. J Clin Psychopharmacology 1982: 2: 345-349.
8. WADDINGTON JL, YOUSSEF HA, KINSELLA A et al. Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol Med 1990: 20: 835-842.
9. JESTE DV, CALIGIURI MP. Tardive dyskinesia. Schizophr Bull 1993: 19: 303-315.
10. CHOUINARD G, ANNABLE L, MERCIER P et al. A five-year follow-up study of tardive dyskinesia. Psychopharmacol Bull 1986: 22: 259-263.
11. GUY W. ECDEU manual for psychopharmacology. Washington, DC: DHEW. 1976.
12. VAN Os J, FAHY T, JONES P et al. Increased intra-cerebral CSF spaces predict unemployment and negative symptoms in psychotic illness: a prospective study. Br J Psychiatry 1995: 166: 750-759.
13. VAN Os J, FAHY T, JONES P et al. Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychol Med 1996: 26: 161-176.
14. WING JK, COOPER JE, SARTORIUS N. The measurement and classification of psychiatric symptoms. Cambridge: Cambridge University Press, 1974.
15. MCGUFFIN P, FARMER AE, HARVEY I. A polydiagnostic application of operational criteria in psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991: 48: 764-770.
16. NELSON HE. National Adult Reading Test (NART): test manual. Windsor: NFER-Nelson, 1982.
17. WECHSLER D. Wechsler Adult Intelligence Scale: manual. New York: Psychological Corporation, 1955.
18. ANDREASEN NC, RICE JP, ENDICOTT J, REICH T, CORYELL W. The family history approach to diagnosis. How useful is it? Arch Gen Psychiatry 1986: 43: 421-429.
19. LEWIS SW, OWEN MJ, MURRAY RM. Obstetric complications and schizophrenia: methodology and mechanisms. In: (SCHULZ SC, TAMMINGA CA, ed.), New York: Oxford University Press, 1989: 56-58.
20. World Health Organization. WHO coordinated multicenter study on the course and outcome of schizophrenia. Geneva: World Health Organisation. 1992.
21. IAGER AC, KIRCH DG, WYATT R. A negative symptom rating scale. Psychiatr Res 1985: 16: 27-36.
22. REITAN RM. Validity of the trail-making test as an indicator of organic brain damage. Percep Mot Skills 1958: 8: 271-276.
23. BARNES TRE. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia. Psychiatr Dev 1987: 4: 301-319.
24. O'HARA P, BRUGHA T, LESAGE A, WING J. New findings on tardive dyskinesia in a community sample. Psychol Med 1993: 23: 453-465.
25. CARACCI G, MUKHERJEE S, ROTH SD et al. Subjective awareness of abnormal involuntary movements in chronic schizophrenic patients. Am J Psychiatry 1990: 147: 295-298.
26. O'CALLAGHAN E, LARKIN C, KINSELLA A et al. Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia. Br J Psychiatry 1990: 157: 578-584.
27. MORGENSTERN H, GLAZER WM. Identifying risk factors for tardive dyskinesia among chronic out patients maintained on neuroleptic medications: results of the Yale Tardive Dyskinesia Study. Arch Gen Psychiatry 1993: 50: 723-733.
28. GLAZER WM, MORGENSTERN H, DOUCETTE JT. Predicting the long-term risk of tardive dyskinesia in out patients maintained on neuroleptic medications. J Clin Psychiatry 1993: 54: 133-139.
29. DUKE PJ, PANTELIS C, BARNES TR. South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 1994: 164: 630-636.
30. MORGENSTERN H, GLAZER WM, GIBOWSKI LD, HOLMBERG S. Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population. J Chron Dis 1987: 40: 319-327.
31. OLIVEIRA AA, KIKFER MW, MANLEY NK. Tardive dyskinesia in psychiatric patients with substance use disorders. Am J Drug Alcohol Abuse 1990: 16: 57-66.
32. CUESTA MJ, PERALTA V. Lack of insight in schizophrenia. Schizophr Bull 1994: 20: 359-366.
33. JOHNSON DAW, PASTERSKI G, LUDLOW JM, STREET K, TAYLOR RDW. The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences. Acta Psychiatr Scand 1983: 67: 339-352.
34. LEVIN S. Frontal lobe dysfunctions in schizophrenia. II. Impairment of psychological and brain functions. J Psychiatr Res 1984: 18: 57-72.
35. WADDINGTON JL, O'CALLAGHAN E, BUCKLEY P et al. Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging. Br J Psychiatry 1995: 167: 41-44.